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Aims: To evaluate the characteristics of manual haemoglobin methods in use in Malawi and provide
evidence for the Ministry of Health in Malawi to enable them to choose a suitable method for district
hospitals.
Methods: Criteria on accuracy, clinical usefulness, user friendliness, speed, training time, and economic
costs were determined by local health professionals and used to compare six different manual
haemoglobin methods. These were introduced sequentially into use in a district hospital in Malawi
alongside the reference method.
Results: HemoCue was the optimal method based on most of the outcome measures but was also the most
expensive (US$0.75/test). DHT meter and Jenway colorimeter were the second choice because they were
cheaper (US$0.20–0.35/test), but they were not as accurate or user friendly as HemoCue.
Conclusions: The process for choosing appropriate laboratory methods is complex and very little guidance
is available for health managers in poorer countries. This paper describes the development and testing of a
practical model for gathering evidence about test efficiency that could be adapted for use in other resource
poor settings.
A
s part of the Malawi government’s Poverty Reduction
Strategy, the Ministry of Health and Population has
developed an Essential Health Package.1 This aims to
provide better access to quality services for common
conditions that disproportionately affect the poor. In
Malawi, all health care is free so patients do not pay a fee
for the service. To complement the Essential Health Package,
the Ministry of Health and Population is developing a model
package of essential laboratory services to improve the cost
effectiveness of district hospital laboratories. The model is
being developed and piloted in selected typical district
hospitals in Malawi before being adapted for national
implementation. Haemoglobin measurement is a key com-
ponent of this service, so it is necessary to identify a method
that is practical, accurate, and economically viable for use at
district level.
‘‘This is the first time that such a detailed effectiveness
study involving all the processes required to determine the
suitability of a test has been undertaken in a district
hospital in a developing country’’
Haemoglobin measurement is the most commonly per-
formed laboratory test worldwide and is an essential
component of any health system. In sub-Saharan Africa,
haemoglobin estimations are used in district hospitals for
individual patient management, to guide transfusion prac-
tice, and in the management of antiretroviral therapy.
Surveys of haemoglobin concentrations are also used as tools
to provide public health data, such as nutritional status, and
to monitor malaria interventions. Despite the wide range of
manual methods available for measuring haemoglobin in
developing countries, no single technique has emerged as the
most appropriate for this setting.
To support their Essential Health Package,1 the Ministry of
Health and Population in Malawi needed to identify a
method for measuring haemoglobin that was simple,
accurate, fast, and cheap and required minimal training
and supervision that could be used in district hospital
laboratories. Therefore, our study assessed the effectiveness,
including technical, economic, and managerial aspects, of
different manual techniques for measuring haemoglobin in
routine practice in a typical district hospital in Malawi
against criteria predetermined by local heath professionals.
To our knowledge, this is the first time that such a detailed
effectiveness study involving all the processes required to
determine the suitability of a test has been undertaken in a
district hospital in a developing country. The project received
ethical approval from the Liverpool School of Tropical
Medicine, UK and the Ministry of Health and Population in
Malawi.
MATERIALS AND METHODS
Our study was carried out in Ntcheu District Hospital in the
central region of Malawi. This district has a population of
500 000 and is served by a single hospital with 240 inpatient
beds. The laboratory in the Ntcheu District Hospital performs
approximately 6000 haemoglobin tests each year. It normally
has a complement of two or three staff (laboratory assistants
and qualified technicians), but two extra technicians were
seconded to assist with our study.
The six haemoglobin methods to be evaluated were chosen
because they were already in use in Malawi or at district level
in other countries, and they could be supplied quickly for
widespread use in Malawi.
The Lovibond comparator (ECHO International Health
Services Limited, Coulsden, Surrey, UK)
This is the predominant method used in Malawian district
hospitals and assessments were carried out using the
equipment already in routine use. It is based on the
oxyhaemoglobin method and involves matching the colour
of the diluted blood sample with colours on a disc equivalent
to known haemoglobin values in 20 g/litre increments.2
Abbreviations: HCN, haemiglobincyanide
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WPA colorimeter (WPA CO700D from WPA,
Pocklington, York, UK) and Jenway colorimeter
(Jenway 6051; Jenway, Dunmow, UK)
These methods are based on the conversion of haemoglobin
to haemiglobincyanide. The Jenway colorimeter has a direct
readout.
DHT meter (HMB.010; Developing Health Technology,
Ipswich, UK)
This is based on the oxyhaemoglobin method and has a direct
readout of the haemoglobin estimation.
HemoCue (HemoCue AB-haemoglobin photometer;
Angelholm, Sweden)
Undiluted blood is placed directly into a microcuvette where
the haemoglobin is converted to haemiglobinazide. The
microcuvette is inserted into the photometer and the
machine provides a direct readout of the haemoglobin result.
Haemoglobin colour scale (Copack GmbH;
Oststeinbek, Germany)
A drop of undiluted blood is placed on specific chromato-
graphy paper and matched against a range of colours
representing different haemoglobin values in 20 g/litre
increments.
All methods were performed in accordance with the
manufacturers’ instructions. The methods were evaluated
sequentially on a total of 600 consecutive, unselected EDTA
blood samples (that is, 100 samples for each method) sent to
the laboratory for routine haemoglobin estimations during
a two month period during the malaria season. To assess
the accuracy of each method in routine use, the haemo-
globin value of all samples was also measured by the
haemiglobincyanide (HCN) method3 simultaneously with
the test method, but by different technicians who were
unaware of each other’s results.
Local laboratory technicians and clinicians devised the
criteria by which each method was assessed. The criteria were
designed to identify the method that was most appropriate
for use in district hospitals in Malawi. The criteria comprised:
(1) accuracy and clinical usefulness, (2) user friendliness, (3)
time taken to learn and perform tests, and (4) economic
costs.
Accuracy and clinical usefulness
The level of agreement between haemoglobin values gener-
ated by the individual methods compared with the reference
HCN method was determined according to the statistical
method of Bland and Altman.4 Statistical analyses were
performed using SPSS version 10. The percentage of tests for
each method that varied from the reference value by more
than ¡20 g/litre were regarded as wasted tests. This cutoff
was chosen because local clinicians indicated that a result
that deviated more than 20 g/litre from the true value would
probably result in mismanagement of the patient and was
therefore of no clinical use.
User friendliness
Local technicians themselves identified the five key attributes
of an ideal method for haemoglobin measurement in a
district hospital in Malawi as: technically undemanding,
minimal training and supervision requirements, direct read-
ing of results, simple quality control checks, and not reliant
on electricity supply. The technicians independently rated
each of these criteria on a scale of 1 (very poor) to 5
(excellent) for each test method and this was used to devise a
score of user friendliness for each method (maximum score
for each method, 25).
Time taken to learn and perform tests
As each new method was introduced, the time taken to learn
the method so that laboratory technicians and attendants
could perform it independently was recorded. The time taken
to perform each test during routine use was documented, and
the time spent on internal quality control and calibration
processes for each batch of tests was included in the
calculation and divided between the number of tests for
each batch. The training costs for each method were
calculated from the cost of practice tests and the salary of
the trainee for the total training time. The Lovibond
comparator was excluded from this analysis, because it was
the method already in routine use in the laboratory, so it was
familiar to the technicians.
Table 1 Accuracy of various haemoglobin methods compared with the reference haemiglobincyanide (HCN) method
Method Mean (g/l) Median (g/l) SD Range
95% limit below
reference method
95% limit above reference
method
HemoCue 94 104 46 1.6–16.5 6% 16%
HCN 94 106 46 1.9–16.9
Jenway colorimeter 65 59 30 1.9–16.1 14% 10%
HCN 67 60 30 2.1 –16.3
WBA colorimeter 58 52 25 1.9–14.5 31% 31%
HCN 61 56 28 1.9–16.0
Haemoglobin colour scale 81 80 35 4.0–14.0 48% 37%
HCN 78 72 35 2.3–17.0
DHT meter 81 77 30 2.8–16.8 19% 33%
HCN 75 68 30 1.9–15.4
Lovibond 105 110 36 4.0–14.0 83% 33%
HCN 81 78 40 1.5–16.5
One hundred different samples were used for each method.
Table 2 Clinical usefulness of 100 haemoglobin tests
using different methods
Test method
Variation between haemoglobin results from
test and reference method
0 to
10 g/l
11 to
20 g/l
More than 20 g/l
(‘‘wasted’’ tests)
HemoCue 97 2 1
Jenway colorimeter 96 3 1
WBA colorimeter 76 21 3
DHT meter 67 30 3
Haemoglobin
colour scale
57 27 16
Lovibond 14 27 59
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Economic costs
To estimate the costs for each method, the actual value of all
resources used to perform the 100 haemoglobin estimations
(including control and calibration procedures) was calculated
from: the cost of apportioned annualised capital equipment,
supplies, and technician’s time taken to perform each test. An
appropriate portion of the laboratory’s total electricity costs
was included for all methods that used power. Building
maintenance costs were assumed to be the same, irrespective
of the method, and were therefore excluded from the cost
analysis. These estimations were used to project the total
annual costs of the haemoglobin workload for each method.
Prices were obtained from the Malawi central medical store
catalogue or directly from the suppliers, and included the
standard 12% government discount rate. Costs were
expressed in US$.
RESULTS
Accuracy and clinical usefulness
HemoCue was the most accurate method because it had
mean and range values closest to those of the HCN reference
method (table 1); 95% of HemoCue results differ by only 6%
below and 16% above the reference results. None of the tests
showed systematic bias and the degree of imprecision is
reflected in the limits of agreement. The proportion of tests
that were too inaccurate to be clinically useful varied from 1%
for HemoCue to 59% for the Lovibond comparator (table 2).
User friendliness
HemoCue was rated as the most user friendly method by the
technicians, achieving the maximum possible score of 25. The
least user friendly methods were the reference HCN method
and the WBA colorimeter because neither of these had a
direct readout of the haemoglobin result (table 3).
Time taken to learn and perform tests
Competency was achieved most quickly for the HemoCue
method by both grades of laboratory staff (table 4).
In routine use, the average time taken to perform a single
test varied between three minutes (haemoglobin colour
scale), five minutes (DHT meter, HemoCue, and Lovibond),
and 15 minutes (colorimeters and HCN method). The
training costs to achieve competency varied from US$18 to
US$246, depending on the method. They were lowest for the
DHT meter, the haemoglobin colour scale, and HemoCue.
They were five to 10 times higher for the WBA and Jenway
colorimeter methods and the HCN reference method.
Economic costs (table 5)
There was a fivefold variation in cost/test, from US$0.12 for
the haemoglobin colour scale to US$0.75 for the HemoCue
method.
The projected annual total costs of resources (staff,
supplies, equipment, and overheads) that would be used for
the 6161 haemoglobin estimations performed in Ntcheu
laboratory in 2001 varied from 2001 US$752.4 to 2001
US$4638.3 for the haemoglobin colour scale and HemoCue,
respectively.
DISCUSSION
To our knowledge, this is the first study to provide a detailed
analysis of all the resources, including training inputs and
recurrent costs, actually used to establish and maintain a
variety of haemoglobin methods in an African district
hospital. The criteria for the most appropriate method for
their circumstances were determined by local users. On the
basis of simplicity, speed, accuracy, and short training times,
HemoCue would be the most appropriate method of all those
assessed for district hospitals in Malawi. As a result of our
study, the Ministry of Health and Population in Malawi has
decided to introduce HemoCue as the standard haemoglobin
technique at all their 32 district hospitals and urban health
centres. Its major drawback is the cost of the disposable
cuvettes which comprise 86% of the overall annual cost of
this method, resulting in HemoCue having the highest
annual costs at US$0.75/test. For all other methods except
the haemoglobin colour scale, supplies make up less than
Table 3 User friendliness of different haemoglobin methods
Characteristics (maximum
score 5 each) HemoCue DHT meter
Haemoglobin
colour scale
Jenway
colorimeter Lovibond
WBA
colorimeter
HCN reference
method
Easy to use 5 4 5 4 4 4 2
Minimal training/supervision
required
5 3 5 2 5 2 1
Simple reading of results 5 5 2 5 2 3 3
Simple internal quality 5 2 0 3 0 3 3
Suitable for village use 5 5 5 1 4 1 1
Total (max 25) 25 19 17 15 15 13 10
HCN, haemiglobincyanide.
Table 4 Comparison of training time and costs for different haemoglobin methods
Method
Training time* in minutes Number of practice tests required
Lab
attendant LA/JT
Experienced
technician
Lab
attendant LA/JT
Experienced
technician
Total no of
practice tests
Total training costs
2001 US$
DHT meter 200 90 60 50 40 25 115 18.37
Haemoglobin colour scale 160 60 30 40 20 15 75 24.52
HemoCue 110 50 20 35 20 10 65 45.97
WBA colorimeter 6000 4000 3000 200 150 100 450 228.62
Jenway colorimeter 6000 4000 3000 200 150 100 450 230.32
HCN 7000 5000 4000 200 150 100 450 245.79
*Training time excludes tutor’s time; total training costs comprise trainees’ time, the cost of supplies for the number of practice tests required, and an apportioned
element of the capital cost.
HCN, haemiglobincyanide; JT, junior technician; LA, laboratory assistant.
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50% of the annual costs. Despite its advantages, the high
recurrent costs will probably be a major disincentive for
governments of poor countries to implement HemoCue at
subdistrict levels where the burden of anaemia, and hence
workload, is highest.5 It may be acceptable to compromise
slightly on accuracy for haemoglobin methods that are used
to screen large numbers at community level, as long as the
method is fast and cheap,6 and a more accurate method is
available at the referral hospital. Therefore, it has been
suggested that the haemoglobin colour scale might be
considered for use in antenatal and paediatric screening
programmes. None of the other methods assessed in our
study was ideal for district hospital use, where an accurate
method is essential, because they involve a dilution step. This
is a major source of inaccuracy in poorer countries where
automatic pipettes are unavailable.
‘‘One of the major roles that international organisations
could play would be to provide detailed, independent
evaluations of new laboratory methods’’
The results of our study confirm findings from elsewhere
that show that the Lovibond method currently in use in
Malawi has an unacceptably low accuracy.7 It also indicates
that methods that do not give a direct readout and which
require the construction of calibration curves are technically
too demanding for use in rural laboratories in poorer
countries where the workload is high, many laboratory staff
may have no technical qualifications, and there are no
supervisory systems. The inputs needed to support the
general laboratory system, such as training programmes,
supervisory visits, and participation in external quality
assurance systems, have not been included in our analysis.
However, the simplest methods with the shortest training
times will probably be those that require the least external
supervision and monitoring.
Our study demonstrates the complexity of the decision
making processes that are involved in an apparently simple
task of deciding on an appropriate haemoglobin method for
district hospitals in Malawi. In consultation with local users,
we have developed and tested a model that can be used to
assist in this process, and which could be adapted to suit
other types of health technology and other settings. The
appropriateness of tests will vary according to local clinical
need and resources available, so the results of our study
cannot be extrapolated directly to other studies. However, the
evidence gathering, analysis, and decision making processes
that we have described and that were developed in close
collaboration with local users and suppliers of laboratory
services, provide a model that could be adapted to other tests
and settings.
Health managers in poorer countries do not have technical
training in laboratory issues and have great difficulty in
obtaining the evidence that will enable them to make rational
decisions about purchasing technological services. They need
to take account not only of costs, but also simplicity,
accuracy, speed, available manpower, and technical skills of
their laboratory workforce and the health needs of the
population. Although the World Health Organisation does
provide guidance on the selection of laboratory tests,8 9 details
of all the components needed to make an evidence based
judgement, such as we have provided in our study, are
lacking. One of the major roles that international organisa-
tions could play would be to provide detailed, independent
evaluations of new laboratory methods, which include
information about start up and recurrent costs, training
duration and costs, complexity of the method, and the inputs
needed to maintain calibrations and quality. This type of
independent and comprehensive information would be
invaluable to health purchasers in developing countries,
who face conflicting pressures over equipment purchase from
agencies such as bilateral donors, charities, and the com-
mercial sector.
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Table 5 Projected costs of resources for annual haemoglobin workload (6161 tests) in Ntcheu District Hospital using different
methods (in 2001 US$)
Haemoglobin colour
scale (%)
Lovibond
(%)
DHT meter
(%)
WBA colorimeter
(%)
Jenway colorimeter
(%) HCN (%) HemoCue (%)
Staff* 202.8 (27.0) 338.0 (36.0) 338.0 (27.5) 1013.9 (46.7) 1013.9 (46.4) 1013.9 (28.8) 338.0 (7.3)
Supplies 549.6 (73.0) 472.3 (50.3) 472.3 (38.4) 657.0 (30.3) 657.0 (30.1) 1587.1 (45.2) 3990.1 (86.0)
Equipment 0 (0) 129.1 (13.7) 183.3 (14.9) 264.7 (12.2) 278.6 (12.7) 677.3 (19.3) 74.1 (1.6)
Overheads 0 (0) 0 (0) 236.1 (19.2) 236.1 (10.9) 236.1 (10.8) 236.1 (6.7) 236.1 (5.1)
Total 752.4 939.4 1229.7 2171.7 2185.6 3514.4 4638.3
Cost/test 0.12 0.15 0.20 0.35 0.35 0.57 0.75
*Staff costs include the time taken to perform 6161 tests for each method; the cost of the time taken to calibrate machines was negligible; the costs included in
supplies are those associated with performing a test, the control test, and the material necessary for calibration.
HCN, haemiglobincyanide.
Take home messages
N We assessed six haemoglobin tests currently in use in
Malawi, taking into account accuracy and clinical
usefulness, user friendliness, time taken to learn and
perform tests, and economic costs
N On the basis of simplicity, speed, accuracy, and short
training times, HemoCue was the most appropriate
method and will be introduced as the standard
haemoglobin technique in all Malawian district hospi-
tals and urban health centres
N However, the high recurrent costs of this test mean that
the haemoglobin colour scale might be considered for
use at the community level, with the more accurate
HemoCue method being available at the referral
hospital
N We found that the process for choosing appropriate
laboratory methods is complex and very little guidance
is available for health managers in poorer countries
N We have developed and tested a practical model for
gathering evidence about test efficiency that could be
adapted for use in other resource poor settings
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Single sample doubles as cervical and chlamydia screen
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S
creening for chlamydia is potentially possible at first invitation for cervical screening
with a liquid based system for collecting samples, a feasibility study in England has
shown. The National Institute for Clinical Excellence has since approved liquid based
cytology for national cervical screening.
Samples obtained by conventional means for chlamydia testing and by the ThinPrep Pap
test system for cervical screening, when tested for chlamydial DNA by ligase chain reaction
(LCR), all showed concordant results between sample pairs. Nineteen were positive for
chlamydia and 562 negative out of 581 samples. A subset of 16 positive samples stored at
ambient temperature remained positive for at least five months—the time of reporting. The
double call-recall service for chlamydia and cervical smears that is provided locally would be
an issue for national screening, though, the authors predict.
Three colposcopy services—two hospital services and a community based service—in
Wirral, north west England, took part. The study directly compared suitability of residual
sample from the ThinPrep test system with a paired conventional swab sample taken
immediately afterwards for detecting chlamydia by standard LCR during May 2001–2. The
ThinPrep test system uses a sampling device to collect cervical cells into a transport medium
for later cytological examination.
Detecting chlamydia early would reduce potential complications of the infection and
public health costs of about £100m a year. The study extends a government funded pilot
screening programme with the LCR system within a national strategy to improve sexual
health.
m Hopwood J, et al. Sexually Transmitted Infections 2004;80:371–373.
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